|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1001 G Street, NW |
Address2 | Suite 425W |
| City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 9897-12
|
||||||||
|
6. House ID# 308370000
|
||||||||
| TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Michael Giuliani |
Date | 7/20/2022 11:34:01 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR.2256/S.834 - Resident Physician Shortage Reduction Act of 2021
HR2503 Social Determinants Accelerator Act
HR. 379 - Improving Social Determinants of Health Act of 2021
S 3506 The Strengthening the Public Health Workforce Act
HR 5376 Build Back Better Act
HR 6578 Public Health Workforce Loan Repayment Act
HR 6000 Cures 2.0
HR 1868 - to prevent across-the-board direct spending cuts and other purposes
HR 1319 - American Rescue Plan Act
Paul Coverdell Forensic Science Grant Program
S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021
The Health Workforce Resilience Act
Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas
CLIA Waiver
HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
HR7585 - Health Equity and Accountability Act of 2022
Patent Reform
FDA Safety and Landmark Advancements (FDASLA) Act
Right Drug Dose Now (Right) Act
PREVENT Pandemics Act
HR5602 - BIO Preparedness Workforce Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Giuliani |
|
|
|
John |
Scott |
|
|
|
Darren |
Fenwick |
|
|
|
Michael |
Hurlbut |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S.510 - Protecting Medicare and American Farmers from Sequester Cuts Act of 2021
HR 5376 Build Back Better Act
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes.
HR 3502 - Protecting People from Surprise Medical Bills Act
HR 3630 - to amend title XXVII of the Public Health Service Act
HR 1384 - Medicare for All Act of 2019
HR 861 - End Surprise Billing Act of 2019
S 1266 - Protecting Patients from Surprise Medicare Bills Act
S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019
S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
HR 345 - SMASH Act
S 1213 - Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patents
HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
HR7213 - The Equitable Community Access to Pharmacist Services Act Infrastructure Investments and Jobs Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
John |
Scott |
|
|
|
Michael |
Giuliani |
|
|
|
Darren |
Fenwick |
|
|
|
Michael |
Hurlbut |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |